ZyVersa Therapeutics Inc (ZVSA)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
ZyVersa Therapeutics Enterprise Value: 0.9921M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 0.9921M |
| November 14, 2024 | 1.044M |
| November 13, 2024 | 1.167M |
| November 12, 2024 | 1.177M |
| November 11, 2024 | 1.218M |
| November 08, 2024 | 1.321M |
| November 07, 2024 | 1.445M |
| November 06, 2024 | 1.466M |
| November 05, 2024 | 2.495M |
| November 04, 2024 | 1.754M |
| November 01, 2024 | 1.846M |
| October 31, 2024 | 1.949M |
| October 30, 2024 | 1.950M |
| October 29, 2024 | 1.980M |
| October 28, 2024 | 2.032M |
| October 25, 2024 | 2.042M |
| October 24, 2024 | 2.011M |
| October 23, 2024 | 2.083M |
| October 22, 2024 | 2.145M |
| October 21, 2024 | 2.248M |
| October 18, 2024 | 2.248M |
| October 17, 2024 | 2.206M |
| October 16, 2024 | 2.206M |
| October 15, 2024 | 2.248M |
| October 14, 2024 | 2.266M |
| Date | Value |
|---|---|
| October 11, 2024 | 2.268M |
| October 10, 2024 | 2.299M |
| October 09, 2024 | 2.279M |
| October 08, 2024 | 2.289M |
| October 07, 2024 | 2.217M |
| October 04, 2024 | 2.186M |
| October 03, 2024 | 2.206M |
| October 02, 2024 | 2.227M |
| October 01, 2024 | 2.279M |
| September 30, 2024 | 2.351M |
| September 27, 2024 | 2.309M |
| September 26, 2024 | 2.248M |
| September 25, 2024 | 2.176M |
| September 24, 2024 | 2.134M |
| September 23, 2024 | 2.104M |
| September 20, 2024 | 2.145M |
| September 19, 2024 | 2.217M |
| September 18, 2024 | 2.382M |
| September 17, 2024 | 2.423M |
| September 16, 2024 | 2.33M |
| September 13, 2024 | 2.124M |
| September 12, 2024 | 2.176M |
| September 11, 2024 | 2.556M |
| September 10, 2024 | 2.598M |
| September 09, 2024 | 2.659M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9091M
Minimum
Jan 19 2024
71.35M
Maximum
Dec 13 2022
5.495M
Average
3.193M
Median
Apr 18 2024
Enterprise Value Benchmarks
| NeuroBo Pharmaceuticals Inc | -2.542M |
| Dermata Therapeutics Inc | -3.473M |
| Cognition Therapeutics Inc | -9.839M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.764M |
| Total Expenses (Quarterly) | 2.754M |
| EPS Diluted (Quarterly) | -3.31 |
| Earnings Yield | -6.69K% |